Pliant Therapeutics, Inc.

PLRX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001746473

SEC filings (opens in a new tab)

No open-market purchases or sales by Pliant Therapeutics, Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $54.8M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Pliant Therapeutics, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of PLRX: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	144	1	151	+8
Shares	63.9M	4.97M	63.5M	+4.54M (+7.7%)
Value	$687.2M	$53.4M	$710.6M	+$76.9M (+12.1%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held Pliant Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to PLRX in Q3 2024
Institution	Shares	Value	% of portfolio
BlackRock, Inc.	5,218,965	$58.5M	0.00%
Paradigm Biocapital Advisors LP	3,104,486	$34.8M	1.22%
Integral Health Asset Management, LLC	300,000	$3.36M	0.40%
Natixis	55,000	$616.5K	0.00%
Connor, Clark & Lunn Investment Management Ltd.	34,611	$388.0K	0.00%
Y-Intercept (Hong Kong) Ltd	30,471	$341.6K	0.02%
Allianz Asset Management GmbH	14,600	$163.7K	0.00%
Intech Investment Management LLC	12,913	$144.8K	0.00%
Engineers Gate Manager LP	12,229	$137.1K	0.00%
Teacher Retirement System of Texas	12,104	$136.0K	0.00%
Letko, Brosseau & Associates Inc	10,400	$116.6K	0.00%
Brevan Howard Capital Management LP	10,260	$115.0K	0.01%
Profund Advisors LLC	10,077	$113.0K	0.00%
Gallagher Fiduciary Advisors, LLC	10,009	$112.2K	0.02%
Atria Investments LLC	10,009	$112.2K	0.00%
Public Employees Retirement Association of Colorado	4,422	$50.0K	0.00%
Federated Hermes, Inc.	2,209	$24.8K	0.00%
CWM, LLC	479	$5.00K	0.00%
Versant Capital Management, Inc	262	$2.94K	0.00%
Sterling Capital Management LLC	204	$2.29K	0.00%
Truvestments Capital LLC	167	$1.87K	0.00%
Signaturefd, LLC	124	$1.39K	0.00%
Northwestern Mutual Wealth Management Co	30	$336	0.00%
Allworth Financial LP	2	$23	0.00%

Sold out (16)

Institutions that held Pliant Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of PLRX in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
Laurion Capital Management LP	2,498,920	$26.9M
Casdin Capital, LLC	1,000,000	$10.8M
PDT Partners, LLC	63,352	$681.0K
Verition Fund Management LLC	56,501	$607.4K
Artia Global Partners LP	50,000	$537.5K
Acuta Capital Partners, LLC	46,200	$496.6K
Balyasny Asset Management LLC	31,910	$343.0K
Nebula Research & Development LLC	24,904	$267.7K
Dynamic Technology Lab Private Ltd	17,487	$188.0K
Corton Capital Inc.	15,996	$172.0K
Quantbot Technologies LP	15,261	$164.1K
Deerfield Management Company, L.P. (Series C)	11,678	$125.5K
D. E. Shaw & Co., Inc.	10,679	$114.8K
Clear Street Markets LLC	5,532	$59.0K
Advisor Group Holdings, Inc.	360	$3.87K
Quarry LP	104	$1.12K

Not filed for Q3 2024 yet (1)

Institutions that held Pliant Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PLRX in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
BlackRock Inc.	4,971,639	$53.4M